Stockwinners Market Radar for April 24, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

18:22 EDT Otis Worldwide CEO: We delivered for our shareholders in Q1 - In an interview on CNBC's Mad Money, Judy Marks said input costs are moving in the right direction. "The China market is service business for us. I'm not going to prematurely call a trough in China," she noted. She expects strong performance from North America in FY24.

17:48 EDT Mativ names Kimberly Ritrievi chair of the board - Mativ Holdings announced it has appointed Dr. Kimberly E. Ritrievi as Chair of the Board of Directors, succeeding Dr. John D. Rogers, who will continue to serve as a director of Mativ and will assume the role of Audit Committee Chair. Dr. Ritrievi has served on the Company's Board of Directors since 2018, most recently serving as Chair of the Audit Committee. She is currently President at The Ritrievi Group, LLC and has served as a director of Tetra Tech, Inc. since 2013, currently serving on the Audit Committee and chairing the Strategic Planning and Enterprise Risk Committee. "I am honored to be asked to lead a talented, committed and diverse group of accomplished directors," Ritrievi stated. "My main focus will be on aiding the board and our dedicated Mativ employees to create value for all of our stakeholders. I look forward to advancing Mativ's ambition and path forward as it strives to make material impacts around the world and find potential in the impossible."

17:35 EDT Ford CEO says FY24 CAPEX will likely be at low end of guided range - CEO Jim Farley says: "this year, we expected to spend about $10 billion as a company. We've now guided $8 billion to $9 billion will probably be on the low end of that range. And we're being very consistent about our discipline on profitability. We expect every one of our EVs to make money in the first 12 months, and that is a very disciplined process. In fact, we delayed the launch of our 3-row crossover, which is a great product, 2 years, not only to match the slower growth in EV but more importantly to take advantage of new battery chemistry and formats to substantially reduce the cost of the batteries for that vehicle. We'll do everything it takes to be profitable in the first 12 months of our vehicles."

17:33 EDT IBM says Q1 free cash flow 'strongest in years' - Says Q1 free cash flow of $1.9B up $600M y/y. Expects HashiCorp (HCP) deal to be accretive to adjusted EBITDA in first year post close. Remains "committed" to dividend. Says continues to invest in emerging technologies. Says very strong liquidity position. Reports Q1 signings growth of 4%. Says overall backlog "remains healthy." Says well positioned to grow revenue, free cash flow for the year. Comments taken from Q1 earnings conference call.

17:15 EDT Meta Platforms says Meta AI rollout is going well - Says tens of millions of people have already tried Meta AI. Says Meta AI now creates animations from still images. Says pleased with Llama 3. Says scaling cape and energy expenses for Ai. Says will still grow investment envelope meaningfully before making revenue from these new products. Says expects to see multiyear investment cycle before fully scaling. Says 30% of posts on Facebook and 50% of posts on Instagram feed are AI recommended. Says will continue to carefully manage headcount. Says meaningful market for fashionable AI glasses without holographic display. Comments taken from Q1 earnings conference call.

17:12 EDT Textron awarded $121.28M Navy contract modification - Textron was awarded a $121.28M modification to a previously awarded firm-fixed-price contract. This modification exercises options for the production and delivery of 14 Multi-Engine Training System aircraft in support of providing intermediate and advanced training platform for accession into P-8, EP-3, KC-130, E-6, E-2, CMV-22 and MV-22 for the Navy, Marine Corps, and Coast Guard to support the mission of Chief Naval Air Training to produce aviators and flight officers in sufficient quantity to support Naval Air Forces tasking. Work is expected to be completed in September 2025. FY24 aircraft procurement funds in the amount of $121.28M will be obligated at the time if award, none of which will expire at the end of the current fiscal year. Naval Air Systems Command is the contracting activity.

17:05 EDT Oceaneering affirms consolidated and segment guidance for FY24 - The company states: "Full-year 2024 consolidated and segment guidance remains the same as provided in the fourth quarter 2023 earnings release, inclusive of the following clarification and addition: SSR revenue increase is expected to be in the low- to mid-teens percentage range; and Manufactured Products book-to-bill ratio is expected to be in the range of 1.1 to 1.3 for the full year."

17:05 EDT Oceaneering sees Q2 EBITDA $80M-$90M - The company states: "On a consolidated basis, second quarter 2024 operating results are expected to improve, with EBITDA in the range of $80 million to $90 million on a mid-teens percentage increase in revenue."

17:01 EDT Mannatech announces expansion into Thailand - Mannatech announced a significant milestone in its expansion efforts. Mannatech announced its continued expansion into the ASEAN region, with the official launch into the Thailand market. This opening will bring Mannatech's global presence to 26 markets.

16:59 EDT Ball Corp. board approves repurchase of up to 40M common shares - Ball Corporation's board of directors declared a cash dividend of 20c per share, payable June 17, 2024, to shareholders of record as of June 3, 2024. In addition, the board also approved the repurchase by the company of up to a total of 40M shares of its common stock. The repurchase authorization replaces all previous authorizations. "Today's increased share repurchase authorization will enable our ongoing multi-year return of capital to shareholders," said Howard Yu, executive vice president and chief financial officer.

16:49 EDT ADT Inc. names Jeff Likosar as CFO - ADT Inc. announced that Jeff Likosar has been named CFO. In addition to his duties as President, Corporate Development and Chief Transformation Officer, which he will retain, Likosar had been serving as interim CFO since December 2023. He previously served as the company's CFO from 2017 to 2022. Along with customary CFO responsibilities, Likosar will remain responsible for corporate development, strategy, and transformation execution.

16:42 EDT Chipotle gains 3% to $3,025 after Q1 earnings beat

16:40 EDT IBM falls 8% to $170.12 after Q1 results, confirming acquisition of HashiCorp

16:34 EDT SeaChange to be acquired by Enghouse, terminates Partner One transaction - SeaChange International has entered into an asset purchase agreement under which an affiliate of Enghouse Systems Limited will acquire substantially all of SeaChange's assets related to its product and services business and will assume certain liabilities, for a total purchase price of $39M less SeaChange's cash and cash equivalents at closing The Company currently expects the transaction will result in net proceeds to SeaChange of between $21 to $23M ..The Enghouse Asset Sale, which has been approved by SeaChange's Board of Directors is subject to various terms and closing conditions, including approval by a majority of the shares of SeaChange's outstanding common stock. Subject to such closing conditions, Closing is expected to occur in early May 2024. "When we set out to identify a strategic partner for SeaChange, our two key goals were to maximize stockholder value and to find a larger home for the SeaChange assets within which the business could scale. With Enghouse's commitment to SeaChange and their customer-centric vision for the business, both goals are met. Enghouse has a remarkable track record of embedding software businesses into their highly efficient operational framework, and we are looking forward to seeing SeaChange thrive within the Enghouse family," said Chris Klimmer, CEO at SeaChange.

16:32 EDT Jefferies CEO Handler sells 1.5M shares of stock - Jefferies Financial Group announced that its Chief Executive Officer, Rich Handler, sold 1.5M shares of Jefferies stock today at $43.50. The sale was made to facilitate the purchase of a personal boat and to pay tax obligations. For the 34 years since joining Jefferies in 1990, Mr. Handler has received approximately 70% of his compensation in the form of Jefferies shares and, except for tax purposes and charitable donations, has never sold shares. Following this sale, Mr. Handler owns on a fully diluted basis approximately 19.25 million Jefferies shares. Today's sale represents approximately 7% of Mr. Handler's aggregate holdings. Mr. Handler stated: "My sale of shares today was a gift to myself and my family, and I do not intend to sell any further shares. I remain extremely bullish on Jefferies and fully committed to helping us continue to build the best independent, global and full service investment banking firm."

16:32 EDT Synopsys announces broad EDA and IP collaborations with TSMC - Synopsys (SNPS) announced broad EDA and IP collaborations with TSMC (TSM) for advanced node designs and have been deployed across a range of AI, high-performance computing, and mobile designs. Among the newest collaborations is a co-optimized Photonic IC flow, addressing the application of silicon photonics technology in the quest for better power, performance, and transistor density. Synopsys also noted the industry's confidence in its digital and analog design flows, production-ready for TSMC N3/N3P and N2 process technologies. The two companies are collaborating on next-generation AI-driven flows, including Synopsys DSO.ai, for design productivity and optimization. In addition, Synopsys is developing a broad portfolio of Foundation and Interface IP on TSMC N2/N2P. In a related announcement today, Keysight, Synopsys, and Ansys introduced a new integrated radio frequency design migration flow from TSMC's N16 process to its N6RF+ technology.

16:31 EDT Ansys announces collaboration with TSMC - Ansys (ANSS) announced a collaboration with TSMC (TSM) on multiphysics software for TSMC's Compact Universal Photonic Engines. COUPE is a cutting-edge Silicon Photonics integration system and Co-Packaged Optics platform that mitigates coupling loss while significantly accelerating chip-to-chip and machine-to-machine communication. TSMC COUPE, along with Ansys multiphysics solutions that are integrated with Synopsys' 3DIC Compiler unified exploration-to-signoff platform, enables the next generation of silicon photonics and co-packaged optics designs for applications in AI, datacenter, cloud, and HPC communications. The work spans multiple areas, including fiber-to-chip coupling, integrated electronic-photonic chip design, power integrity verification, high-frequency electromagnetic analysis, and critical thermal management.

16:24 EDT ClearPoint Neuro initiates limited market release of SmartFrame OR - ClearPoint Neuro announced it has initiated the Limited Market Release for its SmartFrame OR Stereotactic System.

16:21 EDT Antero Resources increases FY24 production guidance range to 3.35 to 3.4 Bcfe/d - Antero is increasing its full year 2024 production guidance to 3.35 to 3.4 Bcfe/d, an increase at the midpoint of approximately 25 MMcfe/d. The higher than expected volumes are driven by higher liquids volumes and capital efficiency gains. Antero is also increasing its full year 2024 C3+ NGL realized price guidance to a range of $0.00 to $1.00 per barrel premium to Mont Belvieu, up from the previous guidance of flat to Mont Belvieu. This increase reflects higher expected realizations from its take-in-kind transactions, including more exposure to premium international prices during 2024. Antero is decreasing its cash production expense guidance by $0.05 per Mcfe at the midpoint to a range of $2.40 to $2.50 per Mcfe reflecting lower fuel costs and lower production and ad valorem taxes.

16:17 EDT Venus Concept announces loan purchase, completes of 1st phase of refinance - Venus Concept announced that on April 23 its existing Main Street Lending Program Loan was purchased by affiliates of Madryn Asset Management, for an undisclosed amount from the City National Bank of Florida with the consent of the Company . Following close of the MSLP Loan Purchase, Venus Concept and Madryn entered into a Loan and Security Agreement , dated April 23 pursuant to which Madryn provides an aggregate principal amount of up to $5.0Min debt financing to the Company to support near-term liquidity requirements. A principal amount of $2.0M net of transaction fees was drawn by the Company at the close of the transaction. ..."Madryn is pleased to support Venus Concept in its continued journey towards restructuring the overall operational and financial profile of the business," said Avinash Amin, MD, Managing Partner at Madryn Asset Management, LP. "Our purchase of the senior debt from CNB and providing bridge financing to the Company is another step in our continued partnership with Venus Concept as it works towards the goal of returning to growth and sustained profitability as a public company."

16:13 EDT IBM to acquire HashiCorp for $35.00 per share in cash, or $6.4B - IBM (IBM) and HashiCorp(HCP) announced they have entered into a definitive agreement under which IBM will acquire HashiCorp for $35 per share in cash, representing an enterprise value of $6.4B. HashiCorp's suite of products provides enterprises with extensive Infrastructure Lifecycle Management and Security Lifecycle Management capabilities to enable organizations to automate their hybrid and multi-cloud environments. Today's announcement is a continuation of IBM's deep focus and investment in hybrid cloud and AI, the two most transformational technologies for clients today. Under the terms of the agreement, IBM will acquire HashiCorp for $35 per share in cash, or $6.4B enterprise value, net of cash. HashiCorp will be acquired with available cash on hand. The boards of directors of IBM and HashiCorp have both approved the transaction. The acquisition is subject to approval by HashiCorp shareholders, regulatory approvals and other customary closing conditions. The company's largest shareholders and investors, who collectively hold approximately 43% of the voting power of HashiCorp's outstanding common stock, entered into a voting agreement with IBM pursuant to which each has agreed to vote all of their common shares in favor of the transaction and against any alternative transactions. The transaction is expected to close by the end of 2024.

16:11 EDT Ethan Allen board raises quarterly dividend to 39c per share - On April 22, 2024, the Company's Board of Directors declared and increased the regular quarterly cash dividend by 8.3% to $0.39 per share, payable on May 23, 2024, to shareholders of record on May 7, 2024. Ethan Allen has a long history of returning capital to shareholders and is pleased to increase its regular quarterly cash dividend.

16:10 EDT Kaman delivers new K-MAX helicopter to Black Tusk Helicopter - Kaman announced it delivered a new medium-to-heavy lift K-MAX(R) helicopter to Black Tusk Helicopter Inc. of Squamish, BC, Canada. Black Tusk performs various external lift projects of every scale, ranging from aerial timber harvesting, ski tower setting, firefighting, and hydroelectric projects.

16:10 EDT Ford CFO: Balance sheet remains 'rock solid'

16:09 EDT Meta reports family DAP of 3.24B on average for March, up 7% year-over-year - Meta Platforms reports family daily active people, or DAP, was 3.24B on average for March 2024, an increase of 7% year-over-year. Ad impressions delivered across its Family of Apps increased by 20% year-over-year. Average price per ad increased by 6% year-over-year.

16:08 EDT IBM to acquire HashiCorp for $35.00 per share in cash, or $6.4B

16:07 EDT Meta Platforms raises 2024 capital expenditures view to $35B-$40B - Meta said: "We anticipate our full-year 2024 capital expenditures will be in the range of $35-40B, increased from our prior range of $30-37B as we continue to accelerate our infrastructure investments to support our artificial intelligence roadmap. While we are not providing guidance for years beyond 2024, we expect capital expenditures will continue to increase next year as we invest aggressively to support our ambitious AI research and product development efforts. Absent any changes to our tax landscape, we expect our full-year 2024 tax rate to be in the mid-teens. In addition, we continue to monitor an active regulatory landscape, including the increasing legal and regulatory headwinds in the EU and the U.S. that could significantly impact our business and our financial results. Q1 was a good start to the year. We're seeing strong momentum within our Family of Apps and are making important progress on our longer-term AI and Reality Labs initiatives that have the potential to transform the way people interact with our services over the coming years."

16:07 EDT Splash Beverage announces Julius Ivancsits as CFO - Splash Beverage Group announced the appointment of Julius Ivancsits as Chief Financial Officer effective April 24th, .Julius is a growth strategist with proven success scaling Public & PE-backed companies in both CPG and B2B organizations.

16:05 EDT Acrivon data for ACR-368 and pipeline program progress presented at event - Acrivon Therapeutics to host a corporate R&D event. The company plans to present initial positive clinical data from the ongoing registrational-intent Phase 2 ACR-368 clinical trials, which showed prospective validation of the proprietary ACR-368 OncoSignature patient selection biomarker test with a 50% confirmed objective response rate ORR in patients with ovarian and endometrial cancers. Acrivon is also sharing new preclinical data for ACR-2316, now with accelerated IND filing timelines, as well as actionable findings with the machine learning-enabled AP3 platform. "Today we present initial clinical data from our ongoing Phase 2 clinical trial which we believe highlights the power of our next generation proteomics-based AP3 precision medicine platform," said Peter Blume-Jensen, M.D., Ph.D., chief executive officer, president, and founder of Acrivon Therapeutics. ..."Today's R&D event provides us an opportunity to present the compelling preclinical data of our AP3-based, rationally-designed ACR-2316 dual WEE1/PKMYT1 inhibitor," said Kristina Masson, Ph.D., M.B.A., co-founder and executive vice president of business operations at Acrivon Therapeutics, Inc. and president and CEO of the company's research subsidiary Acrivon AB. "We are excited to announce our accelerated timelines for IND filing, now expected in the third quarter with potential clinical study initiation now anticipated in the fourth quarter of this year. We believe this potential first-in-class asset, which is specifically designed for superior single-agent activity as demonstrated in preclinical studies against benchmark inhibitors, has the potential to address significant unmet treatment needs against a broad range of tumors in patients with limited treatment options."

16:01 EDT Cadence Design, TSMC expand partnership on IP and photonics design - Cadence Design (CDNS) and TSMC (TSM) have extended their longstanding collaboration by announcing a broad range of innovative technology advancements to accelerate design, including developments ranging from 3D-IC and advanced process nodes to design IP and photonics. This collaboration significantly advances system and semiconductor design for AI, automotive, aerospace, hyperscale and mobile applications and has resulted in the following recent technology achievements: Cadence collaborates with TSMC to infuse the Integrity(TM) 3D-IC platform with new features and functionality: The Cadence Integrity 3D-IC platform, the industry's comprehensive solution certified for all the latest TSMC 3DFabric(TM) offerings, now supports a hierarchical 3Dblox specification developed to integrate multiple chiplets into hierarchies for reuse and modular design. It also includes new features developed to ease chiplet assembly and design, and an automated alignment markers insertion flow to accelerate the design and assembly of stacked chiplets on different interposers and packages. Cadence's digital solutions are certified for TSMC N2 design flow, including Innovus(TM) Implementation System, Quantus(TM) Extraction Solution, Quantus Field Solver, Tempus(TM) Timing Signoff and ECO Solution, Pegasus(TM) Verification System, Liberate(TM) characterization, and the Voltus(TM) IC Power Integrity Solution. The Genus(TM) Synthesis Solution is also enabled for N2 technology. Cadence and TSMC are collaborating on AI-driven Cadence solutions to enable an AI-assisted design flow for productivity and optimization of PPA results. The Cadence Custom/Analog Design Flow is fully certified for TSMC's latest N2 Process Design Kit (PDK): Cadence custom tools optimized for TSMC N2 PDKs include Virtuoso(R) Schematic Editor for design capturing and the Virtuoso ADE Suite for analysis, which are both part of Virtuoso Studio, and the integrated Spectre(R) Simulator. All have been enhanced for managing corner simulations, statistical analyses, design centering, and circuit optimization, which are now common with advanced nodes. Virtuoso Studio has also been augmented to support front-to-back process migration from schematic mapping to optimized design specifications to full-layout place-and-route automation. The Virtuoso Studio and Spectre Simulation platforms, including Spectre X, Spectre XPS and the Spectre RF Option, have achieved the latest TSMC N2 certifications. Cadence and TSMC have worked closely together to release a Virtuoso Studio N16 to N6 RF migration reference flow to substantially reduce turnaround time: Purposed-based instance mapping rapidly retargets schematics, while EMX(R) Planar 3D Solver provides inductor synthesis and EM extraction for nets and components during the design phase. The Virtuoso ADE Suite provides design optimization using Spectre Simulation's RF analysis capabilities, and Virtuoso Studio Layout tools accelerate the reuse and reimplementation of RF layouts while preserving design intent."

15:19 EDT Southwest Transport Workers Union Local 556 vote in favor of new CBA - Southwest Airlines announced that its Flight Attendants, represented by the Transport Workers Union Local 556, voted in favor of a new collective bargaining agreement, or CBA. "In addition to industry-leading compensation increases, the new agreement incorporates refined on-call scheduling for Southwest Airlines Flight Attendants and other quality-of-life enhancements, including company-paid maternity and parental leaves... The contract covering nearly 20,000 Southwest Flight Attendants becomes amendable in 2028," the company stated.

15:09 EDT Smith-Midland announces receipt of Nasdaq letter - Smith-Midland Corporation announced that it received a letter dated April 19, from Nasdaq, indicating that the company was not in compliance with Nasdaq listing rule 5250(c)(1), which requires the timely filing of all required periodic financial reports with the Securities and Exchange Commission. The required filing in question is the company's Annual Report on Form 10-K for the year ended December 31, 2023. The delay in filing the Form 10-K is related to the company requiring additional time to complete its financial reporting close process, as referenced in the recent filing of Form 12b-25. "The company expects to file in the near future. As previously reported throughout 2023, revenue is expected to be higher for the year ended December 31, 2023 than the prior year ended December 31, 2022 resulting in higher net income for the year ended December 31, 2023 than the prior year ended December 31, 2022," the company stated.

14:35 EDT Hawthorn Bancshares raises cash dividend to 19c from 17c per share - Hawthorn Bancshares announced that its board of directors approved a quarterly cash dividend of 19c per common share, payable July 1 to shareholders of record at the close of business on June 15, which represents an increase of 2c per common share from the prior quarter's dividend.

13:58 EDT North American rail traffic up 1.3% for the week ending April 20 - The Association of American Railroads or AAR, reported U.S. rail traffic for the week ending April 20. For this week, total U.S. weekly rail traffic was 474,544 carloads and intermodal units, up 0.8% compared with the same week last year. Total carloads for the week ending April 20 were 216,945 carloads, down 6.7% compared with the same week in 2023, while U.S. weekly intermodal volume was 257,599 containers and trailers, up 8.2% compared to 2023. Seven of the 10 carload commodity groups posted an increase compared with the same week in 2023. They included motor vehicles and parts, up 2,236 carloads, to 16,877; petroleum and petroleum products, up 2,119 carloads, to 10,754; and forest products, up 686 carloads, to 8,427. Commodity groups that posted decreases compared with the same week in 2023 were coal, down 20,796 carloads, to 47,472; nonmetallic minerals, down 854 carloads, to 31,781; and metallic ores and metals, down 704 carloads, to 21,100. North American rail volume for the week ending April 20 on 10 reporting U.S., Canadian and Mexican railroads totaled 330,830 carloads, down 4.1% compared with the same week last year, and 346,266 intermodal units, up 7.1% compared with last year. Total combined weekly rail traffic in North America was 677,096 carloads and intermodal units, up 1.3%. North American rail volume for the first 16 weeks of 2024 was 10,466,666 carloads and intermodal units, up 2.1% compared with 2023. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific Kansas City (CP), Norfolk Southern (NSC), Union Pacific (UNP), Rail Vision (RVSN), Greenbrier (GBX), FreightCar America (RAIL) and Trinity Industries (TRN). Reference Link

13:29 EDT ACNB Corp. raises cash dividend 6.6% to 32c per share - ACNB Corporation, financial holding company for ACNB Bank and ACNB Insurance Services, announced that the board of directors approved and declared a regular quarterly cash dividend of 32c per share of ACNB Corporation common stock payable on June 14 to shareholders of record as of May 31. This per share amount reflects a 14.2% increase over the 28c per share paid in the second quarter of 2023, and a 6.6% increase over the 30c per share paid in the first quarter of 2024. James Helt, ACNB Corporation President and Chief Executive Officer, said, "Our decision to increase the dividend is a testament to the strength of our financial position and our confidence in the future growth and profitability of ACNB Corporation. This dividend declaration also represents our second increase to the quarterly cash dividend in less than a year, and represents the fourth consecutive calendar year the Corporation has increased the quarterly cash dividend."

12:54 EDT Hashicorp trading resumes

12:50 EDT HashiCorp jumps 7% to $31.31 after Bloomberg report of IBM offer

12:36 EDT SunPower finds financial misstatements, sees $15M-$25M income decrease - SunPower disclosed this morning that its Audit Committee determined, based on the recommendation of management, that the company's audited financial statements for the period ended January 1, 2023 and unaudited financial statements for the quarterly period ended April 2, 2023, July 2, 2023, and October 1, 2023 should no longer be relied upon. The company plans to restate, as soon as practicable, the financial statements. SunPower identified misstatements in the audited financial statements for the fiscal year ended January 1, 2023. These misstatements primarily relate t the capitalization of certain deferred costs that did not qualify for capitalization, the classification of certain sales commissions as cost of revenue rather than sales, general and administrative expense, and certain other individually immaterial adjustments. The company estimates that the impact of the aforementioned adjustments is a decrease to income from continuing operations before income taxes and equity in earnings of unconsolidated investees for the fiscal year ended January 1, 2023, in the range of approximately $15M to $25M.

12:32 EDT SunPower eliminating 1,000 positions, over 25% of staff - SunPower told employees today it was eliminating 1,000 positions, more than 25% of its workforce. In a letter to staff, Tom Werner stated: "I'm writing to share difficult news with you as we implement changes across our organization in the days and weeks to come. To position SunPower for the future, we need to achieve financial viability, which includes simplifying our business structure, transitioning away from areas where we have been unable to sustain profitable operations, and improving financial controls. As such, we are moving to a low fixed-cost model that we believe we will be able to better flex when the market is up or down. Specifically, we are winding down our SunPower Residential Installation locations and closing SunPower Direct sales. We are also reducing our workforce to better align our business with our new focus. With this shift, we will reduce our workforce by approximately 1,000 people in the coming days and weeks. While we worked hard to avoid this outcome, the market has been slower to recover than we initially expected. Additionally, we have dedicated resources to improving our financial controls, and will continue to do so. We believe this shift in our strategy is necessary to safeguard the company's future." Reference Link

12:20 EDT Greenlight bought 'medium-sized' Penn Entertainment stake in Q1 - David Einhorn's Greenlight Capital bought a "medium-sized" position in Penn Entertainment during Q1, according to its quarterly letter to shareholders.

12:16 EDT Greenlight bought 'small long position' in Roivant during Q1 - David Einhorn's Greenlight Capital bought a "small long position" in Roivant Sciences during Q1, according to its quarterly letter to shareholders

12:14 EDT Greenlight bought 'small long position' in Roivant during Q1 - David Einhorn's Greenlight Capital bought a "small long position" in Roivant Sciences during, according to its quarterly letter to shareholders.

12:01 EDT Stride rises 8.1% - Stride is up 8.1%, or $4.72 to $62.92.

12:00 EDT Wabtec rises 8.8% - Wabtec is up 8.8%, or $13.01 to $161.49.

12:00 EDT Teledyne falls -12.0% - Teledyne is down -12.0%, or -$48.80 to $358.26.

11:34 EDT Vertiv has seen pipeline for AI projects more than double over last 2 months - Comments taken from Q1 earnings conference call.

11:20 EDT Boeing will explore 'optimal' financing for Spirit transaction - Says looking to protect investment grade credit rating.

11:17 EDT Rogers enters ten-year agreement with Comcast for Xfinity products - Rogers Communications (RCI) announced a 10-year agreement with Comcast (CMCSA) to bring the latest award-winning Xfinity products and technology to Canadians across the country. Soon, millions of Rogers customers will be able to experience the future of entertainment with a new device powered by Entertainment OS, the next generation of connectivity via the best gateways and devices, as well as an expanded suite of home security products and features all developed by Comcast and Xfinity.

11:06 EDT Neo-Concept International Grp Hldngs Ltd trading halted, volatility trading pause

10:52 EDT Boeing sees 'number' of issues to work through on Spirit deal

10:47 EDT Boeing ended Q1 with 60 Dreamliners in inventory

10:45 EDT Boeing: Plan to return 787 production to 5 per month later this year

10:36 EDT Boeing engaged team of quality experts to review work, says CEO Calhoun - Comments taken from Q1 earnings conference call.

10:18 EDT Old Dominion says quarter to date revenues up 5%-6% - Comments taken from Q1 earnings conference call.

10:02 EDT Tegna shareholders re-elect nine board members, approve say on pay proposal - Shareholders of TEGNA Inc. overwhelmingly approved the re-election of nine Board members and an advisory resolution on the compensation of the company's named executive officers. TEGNA shareholders re-elected Board Chairman Howard D. Elias, president and CEO Dave Lougee, Gina L. Bianchini, Stuart J. Epstein, Karen H. Grimes, Scott K. McCune, Henry W. McGee, Neal B. Shapiro and Melinda C. Witmer to the Board of Directors at the company's annual meeting held this morning. Directors will serve one-year terms ending at TEGNA's 2025 annual meeting.

10:00 EDT Wabtec rises 12.0% - Wabtec is up 12.0%, or $17.82 to $166.30.

10:00 EDT Evercore falls -6.7% - Evercore is down -6.7%, or -$13.12 to $182.98.

10:00 EDT New Oriental Education falls -9.1% - New Oriental Education is down -9.1%, or -$8.19 to $81.40.

09:47 EDT Bunge falls -6.6% - Bunge is down -6.6%, or -$7.20 to $102.42.

09:47 EDT Wabtec rises 9.3% - Wabtec is up 9.3%, or $13.86 to $162.34.

09:47 EDT Vertiv Holdings rises 13.3% - Vertiv Holdings is up 13.3%, or $10.54 to $89.71.

09:43 EDT B. Riley says business continued to perform well since year-end - B. Riley Financial said in a statement this morning: "We are pleased to note that our overall business has continued to perform well since year-end. Relative valuations for small and mid-caps are as attractive as we have seen in years, and we are investing to grow our leadership in providing financial services and capital solutions to this underserved market. Since year-end, we have welcomed senior talent, invested in attractive new opportunities, monetized several others, retired $115 million of our outstanding bonds and reduced additional indebtedness by approximately $55 million. Our strategic review process for Great American Group is proceeding on schedule, and we are pleased with the interest we have seen to date. The potential monetization of this unique asset would accelerate our ability to opportunistically retire more debt and invest in our core B. Riley Securities, Advisory and Wealth Management businesses as we double down on our commitment to serving our clients and businesses across the middle market - both as an advisor and principal. We acknowledge the complexities of our business are a result of an aggressive acquisition and investment strategy that has meaningfully diversified our platform. We are continuing to strengthen our processes and procedures to ensure we are best positioned to capitalize on the substantial market opportunities in front of us."

09:42 EDT Cazoo Group trading resumes

09:39 EDT B. Riley says investigation found no involvement with Brian Kahn - As referenced in its annual report, the Audit Committee of B. Riley Financial's board engaged Winston & Strawn as independent counsel to assist the Audit Committee in conducting an investigation of the historical relationship between the company and Brian Kahn as well as certain related allegations asserted against the company by certain short sellers. "The results of the independent investigation confirmed that the Company and its executives had no involvement with, or knowledge of, any of the alleged misconduct concerning Mr. Kahn or any of his affiliates. This independent investigation was conducted subsequent to the Company's February 22, 2024 disclosure of the internal review performed with the assistance of Sullivan & Cromwell LLP as outside counsel," B. Riley Financial noted.

09:35 EDT Cazoo Group trading halted, volatility trading pause

09:28 EDT Nvidia acquires workload management provider Run:ai - Nvidia announced it has entered into a definitive agreement to acquire Run:ai, a Kubernetes-based workload management and orchestration software provider. The company said, "Customer AI deployments are becoming increasingly complex, with workloads distributed across cloud, edge and on-premises data center infrastructure. Managing and orchestrating generative AI, recommender systems, search engines and other workloads requires sophisticated scheduling to optimize performance at the system level and on the underlying infrastructure. Run:ai enables enterprise customers to manage and optimize their compute infrastructure, whether on premises, in the cloud or in hybrid environments." Nvidia said it will continue to offer Run:ai's products under the same business model for the immediate future. Terms of the deal were not disclosed. Reference Link

09:18 EDT Synaptogenix regains compliance with Nasdaq listing rules - Synaptogenix announced that it received notice from The Nasdaq Stock Market on April 22, informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550 for continued listing on The Nasdaq Capital Market. On April 24, 2023, Synaptogenix received notice from the Listing Qualifications Department of Nasdaq indicating that the Company was not in compliance with the Listing Rule.

09:17 EDT Cadiz and Fenner signed a water supply agreement with Solstra - Cadiz announced that the Company and Fenner Gap Mutual Water Company signed a water supply agreement with Solstra Communities California for delivery of 1,275 acre-feet per year of water from the Cadiz Water Supply and Storage Project to support development of more than 4,000 homes for military and working families along the Central California coast. Today's announcement is the first time Cadiz has contracted with a housing developer for water supply. Water supply from Cadiz will be delivered through exchanges of water with regional water contractors utilizing the Company's Northern Pipeline, a 220-mile natural gas pipeline originally built to transport oil from the California coast to Texas oil refineries. Under the terms of the Solstra Agreement, water supply will be made available to Solstra via the Coastal Branch of the State Water Project through an exchange with one or more contractors of the California State Water Project. Cadiz expects to receive net revenue of approximately $850 per AF in 2024 dollars for water purchased by Solstra over the contract term. The Company's Northern Pipeline has a delivery capacity of 25,000 AFY. Following execution of the Solstra Agreement, approximately 65% of the delivery capacity of the Northern Pipeline, or 16,175 AFY, has been reserved under water supply agreements, with the remaining capacity in the final stages of contracting. The Company anticipates final development of the Northern Pipeline conversion project will occur in 2024, with construction beginning in 2025 and commencement of water delivery as early as 2026.

09:14 EDT SEALSQ Corp. announces technology strategy, solutions for IoMT security - SEALSQ Corp announced its technology strategy and solutions for IoMT security for medical and healthcare sectors. SEALSQ is leading the charge in providing security solutions tailored for the burgeoning Internet of Medical Things sector. By leveraging advanced semiconductor technology, SEALSQ ensures that IoT devices in medical and healthcare spheres maintain the highest security standards, essential for safeguarding sensitive patient data. One of SEALSQ's latest chip innovations is the VaultIC408, a secure element that boasts a FIPS 140-3 certified firmware running on a CCEAL5+ level Tamper Resistant hardware platform. This element is fundamental in protecting critical IoMT applications such as home patient monitoring hubs and modules. VaultIC408 design prioritizes efficient operation with minimal reliance on external components, streamlining integration into various applications.

09:11 EDT DMG Blockchain Solutions enters collaboration with PayPal - DMG Blockchain Solutions (DMGGF) announced a strategic collaboration with PayPal (PYPL) and Energy Web to explore ways to decarbonize the Bitcoin blockchain. The companies are working together on developing methods for transacting on the Bitcoin network which would expand its use as a carbon neutral payment rail, thus advancing its application. DMG, Energy Web, and PayPal are working together to publish a research paper, which we collectively believe will benefit users of the Bitcoin network who would like to take advantage of carbon neutral options in their transactions. PayPal, with its focus on developing its bitcoin payment rail, has been a leader in new payment technologies with the introduction of its enhanced services by integrating blockchain technology, launching the PayPal USD stablecoin with Paxos Trust Company in August 2023 for efficient transactions.

09:09 EDT Bogota gets regulatory approval for fifth repurchase program - Bogota Financial announced that it has received regulatory approval for the repurchase of up to 237,090 shares of its common stock, which is approximately 5% of its outstanding common stock as previously approved by the board of directors of the Company. This is the Company's fifth stock repurchase program. Shares may be repurchased in open market or private transactions or pursuant to any trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities and Exchange Commission.

09:08 EDT Lamar Advertising selects Vistar to power its US digital billboard network - Vistar Media announced that Lamar Advertising Company, one of the largest outdoor advertising companies in the world, selected Vistar's content management software, Cortex, to power its network of digital out-of-home billboards across the U.S. The agreement follows a partnership forged in 2023 in which Lamar chose Vistar to run its Denver Transit DOOH network.

09:07 EDT Helius Medical expands stroke clinical program with Shepherd Center - Helius Medical Technologies announced the expansion of its clinical development program for the broadening of the labeling of its marketed PoNS device to include patients recovering from stroke with the participation of Shepherd Center, under the direction of Michael Yochelson, M.D., MBA, FAAN, FAAPMR, Chief Medical Officer. Participating to the Company-sponsored single-arm study, Shepherd Center joins Brooks Rehabilitation as a third clinical site to the overall registrational program. The study aims to evaluate the potential benefit of PoNS Therapy in treating gait and balance deficits in chronic stroke survivors. Shepherd Center has been an impactful participant in the PoNS Therapeutic Experience Program, a Company-sponsored outcome research clinical trial designed to evaluate the impact of subjects' adherence to PoNS Therapy in people with multiple sclerosis, a trial led by Deborah Backus, PT, Ph.D., FACRM, Vice President of Research and Innovation.

09:06 EDT Taboola announces Taboola Select - Taboola announced Taboola Select, a new offering created exclusively for large advertisers that provides access to a curated selection of Taboola's premium editorial partnerships. Taboola Select offers advertisers a way to connect with millions of daily active users on premium destinations. Taboola Select allows advertisers to tap into standalone placements on nearly every part of esteemed publisher sites, including homepages, in mid-article sections and in a new position called Featured Placements. "Taboola is giving advertisers access to the most trusted publishers in the world, to reach consumers," said Adam Singolda, CEO at Taboola. "Reliable and effective performance advertising has always been crucial, as these types of campaigns continue to help brands stay resilient and drive results regardless of industry headwinds. Taboola Select is one of the industry's most unique packages for large advertisers to tap into, to run performance campaigns and to reach consumers at scale. We're combining brand safe environments via our direct relationships with the world's most premium publishers, with prominent ad placements that brands simply can't get anywhere else."

09:05 EDT Capricor Therapeutics announces Type B meeting with FDA for CAP-1002 program - Capricor Therapeutics announced an update from the Company's recent Type-B Chemistry, Manufacturing and Controls meeting with the U.S. Food and Drug Administration on next steps for the Biologics License Application submission with its lead asset CAP-1002 in treating Duchenne muscular dystrophy. The FDA has affirmed alignment with Capricor on the following topics: Pre-BLA Meeting and Rolling BLA Submission: The FDA advised Capricor to include discussion for a pre-BLA meeting and rolling BLA schedule in the upcoming Type-B meeting. Based on this feedback, Capricor has already been granted a subsequent Type-B meeting to be held in the second quarter of 2024 to discuss these topics, with the results of those discussions to potentially lead to an accelerated BLA filing. Capricor plans to share with FDA its HOPE-2 open label extension 3-year safety and efficacy data which is expected to be available in the second quarter of 2024 as part of Capricor's ISS and ISE strategy. Establishment of Non-Clinical Comparability: The FDA agreed that comparability between drug product manufactured at our two different facilities has been demonstrated using the provided analytical comparability data. This allows for the use of CAP-1002 drug product manufactured at our San Diego manufacturing facility upon potential product approval. Data from Cohort B of the HOPE-3 clinical trial will not be necessary for FDA approval of the product.

09:03 EDT Heart Test Laboratories announces EPO application EP3834729 granted - Heart Test Laboratories announced that its European Patent Office, EPO, Application EP3834729 has been granted. Andrew Simpson, Chief Executive Officer of HeartSciences, commented, "We are pleased to receive this latest patent grant which further reinforces our position at the forefront of AI-ECG. This patent is particularly valuable because it covers the use of AI-ECG to produce any echo measure of diastolic function, which is fundamental to screen for a broad range of heart disease at an early stage."

09:02 EDT Autodesk and Nemetschek announce interoperability agreement - Autodesk announced an interoperability agreement with the Nemetschek Group to improve open collaboration and efficiencies for the architecture, engineering, construction and operations, or AECO, and media and entertainment industries. The agreement will enhance existing interoperability between the two companies' industry cloud and desktop products and improve the fluent exchange of information across solutions. Whether constructing buildings or highways or producing media assets, working with cloud-connected tools powers automation and unlocks valuable insights for better decisions at every stage of a project. But too often, people, processes, and data are siloed due to software and file incompatibility, resulting in inefficient workflows. Under the terms of the agreement, Autodesk and the Nemetschek Group will provide mutual access to their APIs and industry clouds, thereby giving developer access to Autodesk solutions including AutoCAD, Revit, 3ds Max and Maya, as well as Autodesk Forma and Autodesk Construction Cloud, similarly to Nemetschek solutions including Allplan, Archicad, Bluebeam, Maxon One, Vectorworks as well as Nemetschek's relevant cloud platforms. This will enable the two companies to improve upon existing data exchanges and open new data-centric workflows that span disciplines and industries.

09:01 EDT noco-noco collaborate with Binex - noco-noco signed a Memorandum of Understanding with Binex to jointly develop agriculture-based carbon-credits. Masataka Matsumura, CEO of noco-noco, conveyed his excitement about the partnership, saying, "We're thrilled to collaborate with Binex as we advance our mission to decarbonize and provide enhanced solutions with quality carbon credit offerings to our customers in the EV and battery manufacturing sector seeking to decarbonize."

08:53 EDT iSun announces 1-for-20 reverse stock split - iSun announced that it will effect a 1-for-20 reverse stock split of its issued Common Stock, effective at 9:00 a.m. Eastern Time on Friday, April 26. Beginning Friday, April 26, the company's common stock will trade on a split-adjusted basis.

08:47 EDT NeoVolta announces Ardes Johnson as CEO - NeoVolta announcde the appointment of Ardes Johnson as its new CEO. Mr. Johnson will officially assume his new role on April 29, 2024. His predecessor, Brent Willson, Founder and CEO of NeoVolta, will continue his role as Chairman of the Board and now serve as CTO. Johnson joins NeoVolta from Meyer Burger Americas, where, as President and General Manager, he spearheaded the company's successful transition to module sales in the U.S.

08:45 EDT Innodata awarded three LLM development programs by Big Tech customer - Innodata has been awarded three new large language model development programs by one of its existing "Magnificent Seven" Big Tech customers. Innodata anticipates that the new programs, once ramped up, will together result in approximately $20 million of additional annualized run rate revenue. Prior to the new awards, annualized run rate revenue from the customer was approximately $23 million. Innodata expects that an amendment to its agreement with this customer reflecting these awards will be signed in the next few weeks. Innodata has already begun work on the newly awarded programs.

08:41 EDT ParaZero receives purchase order from Draganfly - ParaZero Technologies (PRZO) received a significant purchase order from Draganfly (DPRO). This order will feature ParaZero's safety technology integrated into Draganfly's Commander 3XL drones, marking a big step in enhancing the safety and operational capabilities of these drones for critical missions.

08:39 EDT Twin Vee PowerCats details standards included in GFX model line - Twin Vee PowerCats announced more details about its second-generation GFX model line. "Building upon the success of our GFX boats, Twin Vee has designed the next evolution of the GFX to include all-new equipment, amenities, and features that all come standard with our entire model line," stated Joseph Visconti, CEO and President of Twin Vee PowerCats Co. "We're manufacturing the GFX-2 to include newly designed and integrated upgrades to elevate our customer's experience on the water." According to the Company, the heart of the GFX's transformation is the all-digital switching system, which replaces the traditional mechanical switches and circuit breakers used in years past. This upgrade increases the reliability of the boat's power distribution system and is more convenient and flexible for boat owners. Complementing this upgrade is the Command Center Console, which has been redesigned to improve the helm experience. "First, the display on our GFX-2 boats is a 24-inch, all-glass Ray Marine touchscreen interface, which allows for intuitive navigation and control of the boat and works seamlessly with optional tech packages we plan on offering," remarked Visconti. "Next, we've introduced all-new electric or electric hydraulic steering systems, tailored to your specific motor package, that will enhance maneuverability and responsiveness. And we've even installed a freshwater porcelain head on our 280 GFXs and up."

08:37 EDT Captivision partners with Activision's Call of Duty: Mobile - Captivision announced its collaboration with Activision's Call of Duty: Mobile and Framework for the recent installation at the Framework in the Desert afterparty in Coachella Valley. Through this collaboration, Captivision delivered a unique media glass installation over the course of the festival. The collaboration marked the inception of a new area of strategic focus for Captivision dedicated to pushing boundaries and redefining the live entertainment experience. At Framework in the Desert, multiple freight container structures were unveiled that featured Captivision's media glass. This innovative installation served as the canvas for an inspiring display of imagery and content for all in attendance. The media presentation included assets from Activision's Call of Duty: Mobile and Framework, in addition to artwork and animations that enhanced the musical ambiance throughout the weekend.

08:35 EDT HP Inc., Ferrari announce multi-year title partnership - Ferrari (RACE) and HP Inc. (HPQ) announced a multi-year title partnership. The partnership features a shared commitment to advance sustainable innovation and accelerate purposeful technology across the Scuderia Ferrari Formula 1 team, the Scuderia Ferrari Esports team, and the Scuderia Ferrari Driver Academy. In addition, the HP logo will make its debut on the Maranello F1 cars ahead of Miami Grand Prix scheduled for May 3-5, when the team will start competing as Scuderia Ferrari HP. "With technology, performance and exceptional craftsmanship fuelling the future, the partnership between HP and Ferrari is a natural fit," said Enrique Lores, CEO of HP Inc. "Both brands are built on rich histories that have endured the test of time. Through this unique collaboration, we also have an opportunity to reach new audiences, drive business growth, and create lasting impact for our shared clients and communities. Together we will leverage the global stage of racing to accelerate sustainable innovation."

08:34 EDT Smart for Life appoints David Trosin to Advisory Board - Smart for Life has appointed David Trosin, the Managing Director of Health Sciences Certification at NSF International, to the Company's advisory board.

08:33 EDT CDT Environmental announces $11.7M wastewater treatment services contract - CDT Environmental Technology has been awarded a contract valued at RMB 85M, or approximately $11.7M. Initial design and engineering work is underway with CDT and its partner, and the project is scheduled to be completed by the end of 2025. Under the terms of the contract, CDT will develop a state-of-the-art water treatment project covering 11 towns in the Jianyang District of Nanping City, China. The project is designed to manage domestic sewage, curb pollution, and support rural environment improvements throughout the province. Main sewage pipelines and connecting infrastructure focused on improving rural wastewater treatment in the Jianyang District of Nanping City, China, will be built and maintained in collaboration with a leading Chinese engineering and construction firm.

08:32 EDT Workhorse Group adds Milea Truck Sales to Certified Dealer network - Workhorse Group announced the addition of Milea Truck Sales and Leasing to its growing Certified Dealer network. With locations in the Bronx and Brooklyn, Milea Truck Sales and Leasing marks Workhorse's second dealer partner in New York state, 12th dealer nationwide, and its latest addition to the Certified Dealer Program. "Adding a second dealer in New York builds on our commitment to growing vehicle sales in heavily incentivized states across the country," said Workhorse CEO Rick Dauch. "Milea Truck locations in New York City allow us to easily reach thousands of fleet operators. With our W4 CC, W56 and W750 vehicles all available now, we are well-positioned to assist businesses across the tri-state area in carrying out their last-mile delivery needs, while achieving their zero-emission objectives."

08:32 EDT Innovative Eyewear announces new patent applications - Innovative Eyewear announced the filing of two new United States patent applications, a utility application, No. 18/605,092, entitled SMART EYEWEAR HAVING ACCESSIBLE TACTILE CONTROLS and a design application, No. 29/930,655, entitled SAFETY EYEWEAR. Innovative Eyewear also announces receipt of notices of allowance on three smart eyewear design patent applications (patent application Nos. 29/806,204, 29/806/207, 29/806/209) and expects design patents to issue from these three allowed applications after payment of issue fees. The two new patent applications are directed to the Company's new Lucyd Armor smart safety glasses product, planned to be introduced in mid-2024 in response to initial demand from potential customers. The new utility patent application is directed to functional aspects of product, while the new design patent application is directed to the ornamental design of the product. The Company developed Lucyd Armor to meet perceived needs of industrial and medical safety glass users.

08:28 EDT Direct Digital says Marcum resigns as independent registered public accountant - In a regulatory filing, Direct Digital Holdings disclosed that on April 17, Marcum LLP, the company's independent registered public accounting firm, notified the company and the Audit Committee of the company's board of directors of Marcum's decision to resign as the independent registered public accounting firm of the company, effective immediately. "Although their audit was not designed to identify or detect violations of law or fraud, Marcum's resignation was not a result of any violation of law or fraud of the Company identified during its audit procedures to date. The reports of Marcum on the company's consolidated financial statements as of and for the fiscal years ended December 31, 2022 and 2021 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles... The company and the Audit Committee are actively seeking a new independent registered public accounting firm and intend to engage a firm as soon as practicable to complete the audit and file the Form 10-K. However, there can be no assurance as to the timing of such engagement or subsequent completion of any audit. The company expects to authorize Marcum to respond fully to the inquiries of the successor independent accounting firm once engaged, including related to prior years' audits and the identified material weakness described [in the company's filing]," the filing stated. Reference Link

08:20 EDT Whitestone REIT publishes investor presentation on its company strategy - Whitestone REIT announced that it filed an investor presentation with the Securities and Exchange Commission in connection with its 2024 Annual Meeting of Shareholders on May 14, 2024. Highlights of the presentation include: "1) Whitestone's track record of superior performance since David Holeman's CEO appointment in January 2022... Whitestone has achieved some of the highest SS NOI growth among our peers2 since 2022 driven by our high-quality portfolio and a management team that is laser focused on delivering consistent results... 2) Our strong, thoughtfully refreshed Board's demonstrated track record of driving sustainable shareholder value creation... Significant Board refreshment with 3 of 6 Trustees added in the past 2 years, achieving a balance of deep institutional knowledge, diversity and fresh perspectives that complement our long-term growth strategy.... 3) Erez's campaign is not in the best interest of all shareholders. Erez's principal, Bruce Schanzer, is attempting to recycle a playbook from his time as CEO at Cedar Realty Trust, a company plagued by governance issues, reputational concerns and long-term operational and share price underperformance. Erez has demanded a change in Whitestone's Board with the sole purpose of embarking on an immediate sale or liquidation of the Company under adverse market conditions; Erez has offered no substantive operational or strategic ideas... Erez's nominees are wholly unqualified to join our Board."

08:17 EDT Genco Shipping mails letter to shareholders - Genco Shipping & Trading Limited announced it mailed a letter to shareholders in connection with the Company's 2024 Annual Meeting of Shareholders, scheduled to be held on May 23, 2024. Shareholders of record as of March 28, 2024, will be entitled to vote at the meeting. Highlights from the letter include: "Genco's Comprehensive Value Strategy is working: Genco's Board of Directors and management team are positioning the Company to drive returns through volatile drybulk market cycles through compelling dividends, reducing debt and investing in its fleet. The Company is continuing to outperform its peers while maintaining its best-in-class governance. The Genco Board has engaged extensively with Economou: The Board and management team, with external financial advisors, thoroughly reviewed Economou's suggestions, including implementing a repurchase plan, selling ships and commencing a tender offer and determined they are NOT in the best interest of all Genco shareholders. Setting the Record Straight: Economou's public disclosures mischaracterize our interactions and make misstatements about our Board and directors... George Economou, a drybulk competitor of Genco, has initiated a proxy fight to add his director nominee to our Board and advance an agenda, which our Board has thoroughly reviewed and believes is NOT in the best interest of all Genco shareholders. We need your VOTE on the WHITE proxy card for Genco's shareholders," the company said.

08:15 EDT AT&T backs FY24 wireless service revenue growth in the 3% range - Backs FY24 broadband revenue growth of 7%+.

08:14 EDT Immutep announces preliminary topline results from TACTI-003 Cohort B - Immutep Limited announces preliminary topline results from Cohort B of the TACTI-003 Phase IIb trial evaluating eftilagimod alpha in combination with MSD's anti-PD-1 therapy KEYTRUDA as first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma patients with negative PD-L1 expression. The investigational immuno-oncology combination utilizing Immutep's MHC Class II agonist and MSD's PD-1 therapy demonstrates an overall response rate of 26.9% and disease control rate of 57.7% in 26 patients whose tumours do not express PD-L1, according to RECIST 1.1, which compares favourably to historical controls. This new data adds to the body of evidence that efti's novel activation of antigen-presenting cells provides a powerful boost to the immune system, which enhances the potential of immune checkpoint inhibitors. Fundamentally, efti is leading to a significant expansion of memory cytotoxic T cells that anti-PD-(L)1 therapies can act upon. Importantly, as the only MHC Class II agonist in clinical development today, efti is generating a broad anti-cancer immune response in a unique and safe manner across all levels of PD-L1 expression, even in tumours with negative expression.

08:13 EDT Northann enters strategic relationship with Rexil Group of Companies - Northann announce the signing of a strategic relationship with Golden Gate BCE B.V., a subsidiary of Rexil Group of Companies Netherlands, a prominent distributor in the Netherlands. This collaboration aims to enhance the presence of sustainable technology and products throughout Rexil Group of Companies Netherlands and its subsidiaries distribution channels. Under this agreement, Rexil Group of Companies Netherlands will promote Northann Corp's environmentally friendly products, Blue11 and SuperOak, to its extensive network of customers in the Netherlands. This partnership aligns with Northann Corp's commitment to sustainability and innovation, furthering its mission to transform spaces through cutting-edge solutions. "We are thrilled to partner with Rexil Group of Companies Netherlands to bring our sustainable technology and products to a wider audience in the Netherlands," said Lin Li, CEO and President of Northann Corp. "This collaboration underscores our dedication to environmental stewardship and showcases our commitment to providing innovative solutions to our customers."

08:12 EDT Bionano Genomics announces publication on OGM's structural variation detection - Bionano Genomics announced the results of an implementation study conducted by researchers at University Medical Center Groningen that compared optical genome mapping, OGM, to traditional cytogenetic methods for the detection of structural variants, SVs, in bone marrow aspirate, BMA, samples. OGM has been shown to regularly detect SVs missed by other methods, as a result of the higher resolution and sensitivity of OGM. Some of OGM's novel findings, however, are difficult for other methods to validate, because of their resolution limitations. In this paper, researchers used OGM to detect variants in the BMA samples that were missed by traditional methods, and then applied targeted Cas9-directed Nanopore sequencing to validate the variants detected with OGM and define the breakpoints at the base pair level. The study results highlight OGM's ability to provide researchers with a more comprehensive understanding of leukemia subtypes and the potential of targeted Cas9-directed Nanopore sequencing to validate new findings efficiently and at high resolution, compared to other genome analysis methods, including short read or other long read sequencing methods.

08:09 EDT Halliburton gets 'deep water' construction contract by exploration firm Rhino - Halliburton announced it has been awarded a deep water integrated multi-well construction contract by Rhino Resources, a private company engaged in both onshore and offshore energy exploration in Africa. "This collaboration between Halliburton and Rhino Resources marks a strategic milestone to harness the full potential of Namibia's oil and gas sector," said Jean Marc Lopez, senior vice president, Europe, Eurasia, and Sub-Saharan Africa at Halliburton. "Halliburton, with its collaborative approach and solutions engineering, is uniquely positioned to maximize asset value in this block with Rhino Resources. Together, we will establish a standard for innovation and economic growth in the industry." Under this agreement, Halliburton will provide complete solutions to construct exploration and appraisal wells, along with testing services. Halliburton will also extend its country operation facilities to support all product service lines from Namibia to enhance collaboration and maximize asset value for Rhino Resources and Namibian customers...Under this agreement, Halliburton will provide complete solutions to construct exploration and appraisal wells, along with testing services. Halliburton will also extend its country operation facilities to support all product service lines from Namibia to enhance collaboration and maximize asset value for Rhino Resources and Namibian customers.

08:08 EDT Gaming and Leisure Properties appoints Debra Martin Chase to board of directors - Gaming and Leisure Properties announced that Debra Martin Chase has been appointed to the Board of Directors as a new independent director, effective immediately, to fill the vacancy created by the previously disclosed passing of JoAnne Epps. The appointment of Chase to the Board of Directors brings the total number of directors to eight, seven of whom are considered independent according to the listing standards of the Nasdaq Stock Exchange. Chase is the founder and Chief Executive Officer of an entertainment production company doing business as Martin Chase Productions.

08:07 EDT Phunware signs renewals of mobile solutions with major healthcare customers - Phunware announced the renewal or extension of several healthcare and hospitality customer contracts. These renewals underscore the value customers are receiving from Phunware's mobile solutions to enhance the visitor experience for hospital patients and hotel guests. Phunware's mobile healthcare solution offers native apps for iOS and Android, enabling seamless navigation with real-time wayfinding, access to health information through MyChart integration, parking assistance, and convenient physician and service directories. "Hospitality and healthcare providers need technology that grows with them as they integrate the full visitor journey into a mobile platform," said Mike Snavely, CEO of Phunware. "These renewals show the significance of our exceptional mobile experiences and how they generate an investable ROI for our customers."

08:05 EDT Amphenol announces new $2B stock repurchase program - In April, the Company purchased the remaining authorized amount of common stock under the existing three-year, $2B stock repurchase plan. On April 23, the company's board of directors approved a new three-year, $2B open market stock repurchase plan.

08:04 EDT Global Mofy signs agreement to provide services to China content creator - Global Mofy Metaverse announced it has signed a new agreement to provide virtual technology services to one of China's leading content creators. Under the agreement, Global Mofy's proprietary digital asset development platform and software ecosystem, Mofy Lab, will be used to facilitate the production of intricate scenes requiring substantial virtual scene construction for an upcoming television program. Haogang Yang, CEO of Global Mofy Metaverse, stated, "This represents another significant win for us, providing an opportunity for the wider industry to witness the advantages of utilizing Mofy Lab, while consumers reap the rewards of an enhanced, more immersive entertainment experience. We are further solidifying our position as a premier digital asset developer, owner, and licensor by dedicating resources to creating the tools and digital components vital to the AI, virtual, and Metaverse-focused landscape. Our mission is to empower creators to bring their wildest imaginations to virtual life. With endless possibilities and opportunities ahead, we're at the forefront of shaping the future of digital content creation, and focused on unlocking greater value for all shareholders."

08:04 EDT Nokia first Buy America-compliant products rolled of manufacturing line - Nokia announced that the first Buy America-compliant products have rolled off the Sanmina manufacturing line. This significant milestone underscores the company's commitment to providing BEAD applicants with the broadband technology needed for critical infrastructure projects that will help close the digital divide. After announcing its plans with Sanmina, Nokia was able to deliver on its commitment to manufacture Buy America-compliant products in the United States in a record-breaking time. Gary Bolton, President and CEO of the Fiber Broadband Association, said: "Having access to technology that is built in the U.S. is an important requirement for states and infrastructure players seeking to participate in BEAD and the $42.45bn of available broadband funding. The general availability of Buy America-compliant products from leading FBA members like Nokia will be a key contributor to fiber broadband operators completing their mission to connect every American to the power of fiber broadband."

08:02 EDT Norfolk Southern reports Q1 adjusted operating ratio 69.9%

07:57 EDT Syra Health selected by the City of Portland in Maine - Syra Health announced that it has been selected by the City of Portland in Maine for developing a health equity accelerator plan to address social determinants of health within the Greater Portland community. The purpose of the plan is to accelerate improvements in chronic disease outcomes among individuals experiencing health disparities and inequities. yra Health's design of the Accelerator Plan will include implementing evidence-based interventions that improve community-clinical linkages and social connectedness. The interventions may include improving access to care, strengthening access to preventive health services, and building up community support networks. This contract marks the 19th state in which Syra Health has active contracts.

07:55 EDT CureVac implementing organizational redesign in 2024 - Following a comprehensive operational assessment in 2023, CureVac is implementing in 2024 an organizational redesign to streamline structures and reduce operating costs across most areas of the company. The program was initiated with a "voluntary leaver" program, with the aim to reduce 150 positions. The redesign will be tailored to CureVac's business scope and pipeline priorities, significantly increasing efficiency and performance while maintaining a strong focus on innovation and R&D activities. The initiated redesign is expected to result in financial savings from the second half of 2024 onwards and extend the company's cash runway.

07:41 EDT Tesla's Head of Investor Relations Martin Viecha to step down - At the conclusion of the company's earnings conference call yesterday, Martin Viecha stated: "I wanted to let the investment community know that about a month ago, I met up with Elon and Vaibhav and announced that I'll be moving on from the world of Investor Relations. I'll be hanging around for another couple of months or so. So feel free to reach out at any time. But after the seven year sprint, I'm going to be taking a break and spending some good quality time with my family."

07:38 EDT Arrowhead begins Phase 1/2a study of ARO-CFB for mediated kidney disease - Arrowhead Pharmaceuticals announced that it has dosed the first subjects in a Phase 1/2a clinical trial, NCT06209177 or of ARO-CFB, the company's investigational RNA interference RNAi therapeutic, in up to 66 healthy volunteers and patients with complement mediated kidney disease. James Hamilton, M.D., MBA, Chief of Discovery and Translational Medicine at Arrowhead, said: "In preclinical studies, ARO-CFB achieved deep and durable reductions in liver production of complement factor B, which is involved in alternative complement pathway activation and associated with pathogenesis of diseases involving complement activation. ARO-CFB is our second clinical program designed to address diseases associated with activation of the complement pathway, the first being ARO-C3, our Phase 1 program targeting complement component 3. We look forward to further progressing both programs to investigate whether these candidates can address the substantial unmet medical need that remains in the treatment of multiple complement mediated diseases." ARO-CFB is designed to reduce hepatic expression of complement factor B CFB , which plays an important regulatory role in amplifying complement alternative pathway activation and has been identified as a promising therapeutic target. ARO-CFB is being developed as a potential treatment for complement mediated kidney diseases such as immunoglobulin A nephropathy IgAN , which is the most common glomerular disease worldwide and carries a high lifetime risk of progression to end-stage renal disease. Additionally, ARO-CFB may have clinical applications in non-renal diseases involving complement activation.

07:34 EDT Amesite announces beta release of NurseMagic App - Amesite announced the beta release of NurseMagic, an innovative and proprietary app designed for nurses. This new web app uses AI to provide helpful and easy-to-use tools for over 5.2 million nurses, making their daily tasks easier and more efficient. Additionally, with its status as a Joint Provider with PACE, also offers convenient, accredited continuing education programs to nurses on the app, enabling them to meet requirements for licensure. Dr. Ann Marie Sastry, CEO of Amesite, said, "Launching apps enables us to directly reach much larger audiences. We want to equip every nurse on the planet with tools that deliver immediate, qualified information, and address the demands on their time while leveraging their expertise. We intend to partner in this sector as we provide professional learning right on the app, and plan to have more announcements as we roll out additional features."

07:33 EDT Boeing says undertaking 'comprehensive actions' in commercial business - The company said it's "Undertaking comprehensive actions in our commercial business to strengthen quality and safety."

07:31 EDT CureVac names Thaminda Ramanayake chief business officer - CureVac announced that Thaminda Ramanayake has been appointed to the role of chief business officer, effective June 1. Ramanayake joins CureVac from Affini-T Therapeutics, where he served as chief business officer and was responsible for creating the company's business development organization.

07:31 EDT Boeing reports total company backlog of $529B, including over 5,600 airplanes

07:29 EDT CureVac, GSK announce start of Phase 1 part of investigational H5N1 trial - CureVac (CVAC) announced the start of the Phase 1 part of a combined Phase 1/2 study of an investigational influenza A pre-pandemic vaccine candidate developed in collaboration with GSK (GSK). The H5N1 avian influenza virus is considered a potential future pandemic threat, known to sporadically cross species from its original bird host to other animal hosts and humans. The monovalent vaccine candidate is based on CureVac's proprietary second-generation mRNA backbone and encodes an influenza A H5-antigen.

07:28 EDT CureVac appoints Thaminda Ramanayake as CBO - CureVac announced that Thaminda Ramanayake has been appointed to the role of Chief Business Officer, effective June 1, 2024. He joins CureVac from Affini-T Therapeutics, where he served as Chief Business Officer and was responsible for creating the company's business development organization.

07:27 EDT enVVeno Medical presents topline efficacy data from SAVVE trial - enVVeno Medical announced the presentation of topline efficacy data showing significant clinical improvement from the SAVVE U.S. pivotal trial for the VenoValve at the 2024 Charing Cross International Symposium in London, UK. The data being presented shows that for patients experiencing a Clinical Meaningful Benefit, the overall average rVCSS improvement was 8.46 points, including 9.29 points for patients at the two-year milestone, 8.08 points for patients at the one-year milestone, and 8.71 points for patients at the six-month milestone. All rVCSS evaluations were based on the patient's most recent clinical visit, compared to baseline, for a weighted average of eleven months following VenoValve implantation for the Clinical Meaningful Benefit patient cohort. Overall, 94% of the study patients receiving the VenoValve have shown clinical improvement as measured by rVCSS at a weighted-average patient follow-up of 11.04 months for the clinical improvement cohort, and 72% of the study patients have improved the three or more rVCSS points needed to demonstrate the VenoValve's Clinical Meaningful Benefit, at a weighted-average patient follow-up of 11.64 months for the Clinical Meaningful Benefit cohort. Total patient follow-up was 762 months and 582 months, respectively, for the two patient cohorts.

07:23 EDT Tilray announces release of new cannabis flower products added to Good Supply - Tilray Brands announced the release of new cannabis flower products added to the Good Supply 'Bud Squad'. Good Supply's signature Bud Squad product campaign was created to help consumers "understand the true sensory experiences and unique characteristics of the brand's popular range of strains in addition to its flavour profiles," the company said.

07:22 EDT TransAlta achieves commercial operation of 300MW White Rock Project - TransAlta Corporation announced that the combined 300 MW White Rock East and White Rock West wind facilities, located in Caddo County, Oklahoma, have achieved commercial operation. The White Rock wind facilities are fully contracted to Amazon Energy and are currently supplying clean and affordable electricity to our customer. TransAlta's portfolio in the US now totals 820 MW in net operating renewable energy capacity. "We are pleased to bring into service our first clean electricity project in Oklahoma, White Rock, which is our largest wind project completed to date. White Rock was made possible through our long-term customer relationship with Amazon and its commitment to power its operations with 100 per cent renewable energy. Amazon is a global leader in procurement of renewable energy to achieve sustainability and carbon reduction objectives, and we are excited to be a trusted supplier to provide clean and affordable electricity as part of Amazon's decarbonization pledge," said Mr. John Kousinioris, President and Chief Executive Officer of TransAlta.

07:20 EDT Biolojic Design: Nektar exercises license option to develop agonistic antibody - Biolojic Design announced that Nektar exercised its license option to develop a program resulting from the companies' research collaboration initiated in 2021. The research collaboration was established to design and test agonistic antibodies targeting tumor necrosis factor receptor type II, a novel, biologically-validated disease target implicated in a wide range of autoimmune diseases that has been difficult to drug with conventional medicines. The antibody program selected for development is designed to modulate the TNFR2 pathway in order to agonize - or activate - T regulatory cells and other anti-inflammatory cell populations, making this a promising approach to stimulating the immune system in ulcerative colitis, multiple sclerosis, vitiligo, and other autoimmune disease states. Under the 2021 research agreement, Nektar has tested antibodies computationally designed by Biolojic Design to precisely agonize the TNFR2 receptor. Following successful preclinical in vitro and in vivo studies, Nektar decided to exercise the license option and has been advancing the program through IND enabling studies since late December, 2023. If the NKTR-0165 candidate proceeds through clinical development, Biolojic Design is entitled to development milestones and sales royalties.

07:19 EDT PyroGenesis signs energy transition contract with leading global steelmaker - PyroGenesis Canada announces that it has signed a small contract with one of the five largest steelmakers in the world to assess the applicability of PyroGenesis' fully electric plasma torches for use in the client's manufacturing facilities as a primary heat source in the steelmaking process, specifically during the production of direct reduced iron for use in electric arc furnaces. The client's name shall remain anonymous for competitive and confidentiality reasons. The project agreement outlines the initial steps for providing plasma-specific data and analysis in support of the client's energy-transition goals. The first step is a feasibility study to gather initial data for evaluating the potential use of plasma in the client's factories as a process heating source for the DRI process. The duration of the study is approximately 60 days, commencing in April 2024.

07:17 EDT Gold Royalty enters strategic alliance with Taurus Mining - Gold Royalty announced it has entered into a three-year mutual cooperation agreement with Taurus Mining Royalty Fund that provides each party the ability to coinvest in certain precious metals royalties and streams sourced by the other party. The agreement provides a framework for cooperation and communication amongst the parties in the identification and evaluation of potential co-investment opportunities. The agreement grants each party the right but not the obligation to invest between 25% and 50% in select asset transactions with a value of $30M or more. Future dispositions of interests acquired by a co-investment partner through the arrangement will be subject to rights of first offer to the other co-investment partner.

07:15 EDT Trio Petroleum commences oil sales from California assets - Trio Petroleum provided updates on its petroleum assets in Monterey County, California, and Uintah County, Utah. The Company this week will make its first sale and shipment of oil produced at the McCool Ranch Field in Monterey County, California. The Company will ship approximately 2,100 barrels of oil, which were produced primarily from the HH-1 well that was brought back online in late February of 2024. Net of 16.67% royalties and oil trucking costs, the 80% net revenues to TPET from this sale are expected to be approximately $105,000. The Company is also announcing the commencement of drilling activities on the Asphalt Ridge project in Uintah County, UT. A rig is scheduled to be on site this Sunday, and to drill and complete the Company's first well on this asset in the next two weeks.

07:14 EDT Augmedix announces general availability of Augmedix Go - Augmedix (AUGX) announced the general availability of Augmedix Go for emergency departments, marking the launch of the industry's first fully-automated, generative AI powered medical documentation product for EDs across the country. The launch incorporates learnings from a pilot program with HCA Healthcare (HCA), one of the nation's leading healthcare providers. As part of the pilot, ED physicians in four HCA Healthcare hospitals utilized Augmedix Go to automate medical documentation, with the product instantaneously drafting their medical notes from patient visits. "The launch of Augmedix Go in the ED represents our unwavering commitment to develop solutions for health systems that improve their workflows. Our agility and flexible architecture, exhibited by our broad product suite and open network platform, help us address the complex and varying needs of clinicians and providers," said Manny Krakaris, CEO of Augmedix. "We have built a sophisticated platform designed to enable clinicians to be present with their patients while trusting that Augmedix technology is doing administrative work unobtrusively in the background."

07:13 EDT Village Farms expands executive team - Village Farms International announced that it is expanding its executive team with the following new roles: Chief Operating Officer - Ann Gillin Lefever; President, Global Medical Cannabis - Paul Furfaro; and, General Counsel, Global Cannabis - John Harloe. In 2022, Lefever joined the Company as Executive Vice President, Corporate Affairs. Furfaro joined Village Farms in 2023 as Senior Vice President, Strategy. Dr. Harloe joined Village Farms' subsidiary, Balanced Health Botanicals, in 2019 as General Counsel.

07:11 EDT Atai Life announces dosing of first patient in Phase 2a study of BPL-003 - atai Life Sciences announced that the first patient has been dosed in Part 2 of Beckley Psytech's Phase 2a study, evaluating BPL-003 in patients living with Treatment Resistant Depression, TRD. In Part 2 of this open-label Phase 2a study, patients with moderate-to-severe TRD who are on a stable course of certain oral selective serotonin reuptake inhibitor antidepressants will receive a single dose of BPL-003 alongside psychological support to explore the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of BPL-003 as an adjunctive therapy to SSRIs. Patients will be followed for 12 weeks post-dosing. Initial results are expected in H1 2025. Commenting on Part 2 of the trial, Florian Brand, CEO and Co-Founder of atai, said: "Many clinical trials investigating psychedelics require patients to discontinue their existing antidepressant medication. The findings from this adjunctive therapy part of the BPL-003 Phase 2a study will help to inform whether BPL-003 could be a safe and effective therapy in combination with SSRIs, which could allow for broader patient access, should BPL-003 reach approval."

07:10 EDT MAG Silver reports Q1 325,684 tonnes of ore processed in Juanicipio - MAG Silver reports production from Juanicipio for the Q1. Highlights include: Solid throughput: Juanicipio processed 325,684 tonnes of ore in Q1. Despite a routine 4 day maintenance shutdown during the quarter, Juanicipio delivered 3,980 tonnes per operating day milling performance confirming its operational efficiency and ability to quickly pick up where it left off. Continued strong grades: The average silver head grade for the quarter was 476 grams per tonne, or g/t, marginally higher than the previous quarter. This, together with our robust initial reserve as outlined in the recently released technical report, further reaffirms Juanicipio's status as a high-grade mineral deposit with significant long-term potential. Improving recovery: Recovery for the quarter was higher than the previous quarter across all metals showcasing the ongoing operational enhancements and optimization efforts at Juanicipio. Robust production and guidance on track: Juanicipio surpassed expectations with preliminary production estimates of 4.4 million silver ounces and 9,927 gold ounces in Q1. MAG expects to release its comprehensive financial and operational results on May 14.

07:07 EDT Ribbon announces plans for major network modernization program for Verizon - Ribbon Communications (RRBN) announced plans for a major network modernization program with Verizon (VZ) to retire legacy TDM switching platforms and replace their function with modern cloud-based technologies. Verizon is leveraging Ribbon's portfolio of Voice Products including the vC20 Call Controller, G5 Line Access Gateway, G6 Universal Media Gateway, virtual and Cloud-native Session Border Controllers, and other products which allows for the consolidation and replacement of equipment with energy efficient, software-centric platforms while maintaining full feature functionality.

07:04 EDT Travelzoo sees Q2 revenue up year-over-year - The company said, "For Q2 2024, we expect continued growth in revenue year-over-year, albeit at a smaller pace than in 2023. We also expect for Q2 2024 higher profitability year-over-year. In December 2023, we announced the introduction of a membership fee for Travelzoo beginning January 1, 2024. We recognize membership fee revenue ratably over the subscription period. Legacy Travelzoo members as of December 31, 2023 are exempt from the fee during 2024. Therefore, we do not anticipate to generate membership fee revenue from these members before 2025."

07:01 EDT General Dynamics reports backlog of $93.7B, up 4.4% - The consolidated book-to-bill ratio, defined as orders divided by revenue, was 1-to-1 for the quarter. Company-wide backlog of $93.7 billion was up 4.4% from the year-ago quarter. Estimated potential contract value, representing management's estimate of additional value in unfunded indefinite delivery, indefinite quantity contracts and unexercised options, was $40.3 billion. Total estimated contract value, the sum of all backlog components, was $134 billion, up 4.4% from the year-ago quarter. In the Aerospace segment, orders in the quarter totaled $2.4 billion, growing backlog to $20.5 billion, up 6.2% from the year-ago quarter. Aerospace book-to-bill was 1.2-to-1 for the quarter. In the defense segments, orders in the quarter totaled $8.8 billion, with particular strength in Combat Systems and Technologies, which had book-to-bill ratios of 1.6-to-1 and 1.2-to-1, respectively.

06:51 EDT Evercore raises quarterly dividend to 80c per share - On April 23, the Board of Directors of Evercore declared a quarterly dividend of 80c per share to be paid on June 14 to common stockholders of record on May 31.

06:25 EDT GSK: FDA accepts expanded Jemperli indication application for priority review - GSK announced the U.S. Food and Drug Administration accepted the supplemental Biologics License Application, or sBLA, for Jemperli in combination with standard-of-care chemotherapy to expand treatment to all adult patients with primary advanced or recurrent endometrial cancer. This would include patients with mismatch repair proficient /microsatellite stable tumours. Currently, Jemperli is FDA-approved in combination with carboplatin and paclitaxel, followed by Jemperli as a single agent for the treatment of adult patients with primary advanced or recurrent endometrial cancer that is either mismatch repair deficient, as determined by an FDA-approved test, or microsatellite instability-high. The FDA granted Priority Review for this application and assigned a Prescription Drug User Fee Act action date of August 23, 2024.

06:20 EDT Standard Lithium validates performance of largest operating DLE in North America - Standard Lithium announced that it has successfully commissioned and validated the performance of the largest continuously-operating Direct Lithium Extraction, or DLE, equipment in North America. The Company recently installed a commercial-scale DLE column at its Demonstration Plant near El Dorado, Arkansas. The column is a Li-ProTM Lithium Selective Sorption, or LSS, unit, supplied by Koch Technology Solutions, or KTS. The column was installed and integrated into the Company's existing Demonstration Plant, and is currently extracting lithium from Smackover Formation brine at an input flow rate of 90 gallons per minute. This is, to the best of the Company's knowledge, both the largest DLE installation, and the only example of a commercial-scale DLE column in operation in North America. The performance of this commercial-scale DLE column is being used to validate the design assumptions for the Phase 1A Project and also underpins the process design work underway for the South West Arkansas Project.

06:17 EDT Tutor Perini subsidiary awarded $72.7M contract by the city of Pensacola - Tutor Perini announced that its subsidiary, Roy Anderson Corp, has been awarded a contract valued at approximately $72.7M by the City of Pensacola, Florida, for Hangar 3 of Project Titan at Pensacola International Airport. The scope of work includes the design and construction of a new pre-engineered metal building hangar with a central shop and perimeter office and support areas, as well as construction of a new 300 space asphalt parking lot. Design work has commenced, and construction is expected to begin in August 2024 with substantial completion anticipated in the summer of 2026. The contract value was included in the Company's backlog beginning in the Q1 of 2024.

06:13 EDT Virtu Financial announces planned CFO transition - On August 1, Cindy Lee, currently Deputy CFO, will become CFO of Virtu Financial. Sean Galvin, currently CFO of Virtu since 2020, will remain with Virtu in a senior capacity and will work with Cindy to ensure a seamless leadership transition. This transition is the result of the Company's long-term succession planning with respect to the CFO role. A seasoned professional in the financial services sector, Cindy Lee joined Virtu in 2011 where she has held various roles in global finance and most recently as Deputy CFO has overseen global finance and corporate treasury functions.

06:12 EDT Owens Corning sees FY24 general corporate expenses $240M-$250M - Sees FY24 interest expense $70M-$80M; effective tax rate on adjusted earnings 24%-26%; capital additions $550M; and depreciation and amortization $550M.

06:05 EDT Block building own bitcoin mining system, finishes development of 3nm chip - In a blog post on Tuesday, Block said it has finished the development of its own 3nm bitcoin mining chip and is now in the process of working through the design with a "leading global semiconductor foundry." Block also unveiled plans to broaden out the scope of its mining project to include system design. "We've spent a significant amount of time talking to a wide variety of bitcoin miners to identify the challenges faced by mining operators," Block said. "Building on these insights and pursuant to our goal of supporting mining decentralization, we plan to offer both a standalone mining chip as well as a full mining system of our own design." Reference Link

05:21 EDT Travere Therapeutics, CSL Vifor announce EC approval for Filspari - CSL Vifor and Travere Therapeutics announced that the European Commission has granted conditional marketing authorization, or CMA, for Filspari for the treatment of adults with primary IgAN with a urine protein excretion of 1.0 g/day. The CMA is granted for all member states of the European Union, as well as in Iceland, Liechtenstein and Norway.

05:16 EDT Calliditas announces NefIgArd study achieves primary, secondary endpoints - Calliditas Therapeutics announced that the global open-label extension, or OLE, study to the Phase 3 NefIgArd study showed a treatment response consistent with the NefIgArd study across endpoints of urine protein to creatinine ration, or UPCR, and estimated glomerular filtration rate, or eGFR, at nine months across all IgAN patients, including those who had previously received Nefecon in the NefIgArd study. NefIgArd was a global, Phase 3, randomized, double-blind, placebo-controlled, multicenter study designed to evaluate the efficacy and safety of Nefecon 16 mg once daily vs placebo in adult patients with primary IgAN as an addition to optimized RASi therapy. Patients were randomized 1:1 to receive 16 mg/day of Nefecon or matching placebo for nine months, followed by a 15-month observational follow-up period without the study drug. The NefIgArd study achieved both its primary and key secondary endpoints and was the basis for full approval by the FDA in December 2023. The full data set was published in The Lancet. The OLE study was designed to provide nine months of treatment with Nefecon for all patients who completed the NefIgArd study and who at that time had greater than 1g/g of proteinuria over 24h and greater than 30 ml/min of eGFR. All enrolled OLE patients continued on optimized RAS inhibitor therapy and were treated for nine months with Nefecon 16mg per day, with a follow-up visit three months after completion of treatment. Primary assessment was based on UPCR and eGFR at 9 months. A total of 119 patients were enrolled, of whom 45 had previously had active treatment. Topline data from the OLE study showed that the treatment response was consistent with the NefIgArd study's findings regarding the endpoints of UPCR and eGFR at nine months across all patients, irrespective of whether they had previously been treated with Nefecon or with placebo. The safety data after 9 months of treatment or retreatment with Nefecon in patients who completed the NefIgArd study were consistent with previously reported safety data.

05:05 EDT Lithia & Driveway reports Q1 EPS $6.11, consensus $7.89 - Reports Q1 revenue $8.56B, consensus $8.54B. New vehicle same store units grew by 3.6 %. Reports Q1 total vehicle gross profit per unit of $4,346, down $1,239. "In the first quarter, our teams responded as the industry continued to normalize inventories and profitability. We are committed to driving improvements across our business," said Bryan DeBoer, President and CEO. "Our model is diversified with our adjacencies maturing and on a path to profitability, as we continue to deliver the best experience for our customers. Responding to market conditions, we are rebalancing our capital allocation from acquisitions toward returns to our shareholders, with the long-term target of delivering $2 in EPS per billion in revenues."